Works by Webber, Andrea L.

Results: 8

Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease.

Published in:

2020

By:

Cazanave, Sophie;
Podtelezhnikov, Alexei;
Jensen, Kristian;
Seneshaw, Mulugeta;
Kumar, Divya P.;
Min, Hae-Ki;
Santhekadur, Prasanna K.;
Banini, Bubu;
Mauro, Adolfo Gabriele;
Oseini, Abdul M.;
Vincent, Robert;
Tanis, Keith Q.;
Webber, Andrea L.;
Wang, Liangsu;
Bedossa, Pierre;
Mirshahi, Faridoddin;
Sanyal, Arun J.

Publication type:

Correction Notice

Fine‐Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection.

Published in:

Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 6, p. 1325, doi. 10.1002/cpt.1737

By:

Gao, Wei;
Webber, Andrea L.;
Maxwell, Jill;
Anderson, Melanie;
Caro, Luzelena;
Chung, Chris;
Miltenburg, André M.M.;
Popa, Serghei;
Van Dyck, Kristien;
Wenning, Larissa;
Mangin, Eric;
Fandozzi, Christine;
Railkar, Radha;
Shire, Norah J.;
Fraser, Iain;
Howell, Bonnie;
Talal, Andrew H.;
Stoch, S. Aubrey

Publication type:

Article

Location of enhancers is essential for the imprinting of H19 and Igf2 genes.

Published in:

Nature, 1998, v. 391, n. 6668, p. 711, doi. 10.1038/35655

By:

Webber, Andrea L.;
Ingram, Robert S.;
Levorse, John M.;
Tilghman, Shirley M.

Publication type:

Article

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease.

Published in:

Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-17370-6

By:

Cazanave, Sophie;
Podtelezhnikov, Alexei;
Jensen, Kristian;
Seneshaw, Mulugeta;
Kumar, Divya P.;
Min, Hae-Ki;
Santhekadur, Prasanna K.;
Banini, Bubu;
Mauro, Adolfo Gabriele;
M. Oseini, Abdul;
Vincent, Robert;
Tanis, Keith Q.;
Webber, Andrea L.;
Wang, Liangsu;
Bedossa, Pierre;
Mirshahi, Faridoddin;
Sanyal, Arun J.

Publication type:

Article

Biomarkers predictive of response to pembrolizumab in head and neck cancer.

Published in:

Cancer Medicine, 2023, v. 12, n. 6, p. 6603, doi. 10.1002/cam4.5434

By:

Pfister, David G.;
Haddad, Robert I.;
Worden, Francis P.;
Weiss, Jared;
Mehra, Ranee;
Chow, Laura Q. M.;
Liu, Stephen V.;
Kang, Hyunseok;
Saba, Nabil F.;
Wirth, Lori J.;
Sukari, Ammar;
Massarelli, Erminia;
Ayers, Mark;
Albright, Andrew;
Webber, Andrea L.;
Mogg, Robin;
Lunceford, Jared;
Huang, Lingkang;
Cristescu, Razvan;
Cheng, Jonathan

Publication type:

Article

A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.

Published in:

Investigational New Drugs, 2024, v. 42, n. 3, p. 241, doi. 10.1007/s10637-024-01428-0

By:

Chénard-Poirier, Maxime;
Hansen, Aaron R.;
Gutierrez, Martin E.;
Rasco, Drew;
Xing, Yan;
Chen, Lin-Chi;
Zhou, Heng;
Webber, Andrea L.;
Freshwater, Tomoko;
Sharma, Manish R.

Publication type:

Article

Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors.

Published in:

Investigational New Drugs, 2023, v. 41, n. 3, p. 380, doi. 10.1007/s10637-022-01326-3

By:

Stathis, Anastasios;
Tolcher, Anthony W.;
Wang, Judy S.;
Renouf, Daniel J.;
Chen, Lin-Chi;
Suttner, Leah H.;
Freshwater, Tomoko;
Webber, Andrea L.;
Nayak, Tapan;
Siu, Lillian L.

Publication type:

Article

Pharmacological Validation of Candidate Causal Sleep Genes Identified in an N2 Cross.

Published in:

Journal of Neurogenetics, 2011, v. 25, n. 4, p. 167, doi. 10.3109/01677063.2011.628426

By:

Brunner, Joseph I.;
Gotter, Anthony L.;
Millstein, Joshua;
Garson, Susan;
Binns, Jacquelyn;
Fox, Steven V.;
Savitz, Alan T.;
Yang, He S.;
Fitzpatrick, Karrie;
Zhou, Lili;
Owens, Joseph R.;
Webber, Andrea L.;
Vitaterna, Martha H.;
Kasarskis, Andrew;
Uebele, Victor N.;
Turek, Fred;
Renger, John J.;
Winrow, Christopher J.

Publication type:

Article